Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
184,457
clinical trials

Kerato Conjunctivitis Sicca Clinical Trial
Safety and Efficacy of KPI-121 in Subjects With DED
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Long Beach, CA
Click here to add this to my saved trials
Kerato Conjunctivitis Sicca Clinical Trial
Safety and Efficacy of KPI-121 in Subjects With DED
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Mission Hills, CA
Click here to add this to my saved trials
Kerato Conjunctivitis Sicca Clinical Trial
Safety and Efficacy of KPI-121 in Subjects With DED
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Kerato Conjunctivitis Sicca Clinical Trial
Safety and Efficacy of KPI-121 in Subjects With DED
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Rancho Cordova, CA
Click here to add this to my saved trials
Kerato Conjunctivitis Sicca Clinical Trial
Safety and Efficacy of KPI-121 in Subjects With DED
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Rochester, NY
Click here to add this to my saved trials
Kerato Conjunctivitis Sicca Clinical Trial
Safety and Efficacy of KPI-121 in Subjects With DED
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
Kerato Conjunctivitis Sicca Clinical Trial
Safety and Efficacy of KPI-121 in Subjects With DED
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Tampa, FL
Click here to add this to my saved trials
Bacterial Infections Clinical Trial
Study Evaluate the PK Profile of Dalbavancin in Infants and Neonates Patients With Known or Suspected Bacterial Infection
Status: Enrolling, Phase I
Updated: 12/31/1969
Ann & Robert H. Laurie Children's Hopsital
mi
from
Chicago, IL
Click here to add this to my saved trials
Mantle Cell Lymphoma Clinical Trial
Bortezomib in Combination With Ibrutinib in Ibrutinib Relapsed Mantle Cell Lymphoma
Status: Enrolling, Phase II
Updated: 12/31/1969
The University of Michigan Rogel Cancer Center
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Nephrology / Urology, Otolaryngology Clinical Trial
A Study to Evaluate the Safety and Efficacy of CR845 in Chronic Kidney Disease Patients With Moderate-to-Severe Pruritus
Status: Enrolling, Phase II
Updated: 12/31/1969
Cara Therapeutics Study Site
mi
from
Columbus, OH
Click here to add this to my saved trials
Nephrology / Urology, Otolaryngology Clinical Trial
A Study to Evaluate the Safety and Efficacy of CR845 in Chronic Kidney Disease Patients With Moderate-to-Severe Pruritus
Status: Enrolling, Phase II
Updated: 12/31/1969
Cara Therapeutics Study Site
mi
from
Denver, CO
Click here to add this to my saved trials
Nephrology / Urology, Otolaryngology Clinical Trial
A Study to Evaluate the Safety and Efficacy of CR845 in Chronic Kidney Disease Patients With Moderate-to-Severe Pruritus
Status: Enrolling, Phase II
Updated: 12/31/1969
Cara Therapeutics Investigator Site
mi
from
Mineola, NY
Click here to add this to my saved trials
Nephrology / Urology, Otolaryngology Clinical Trial
A Study to Evaluate the Safety and Efficacy of CR845 in Chronic Kidney Disease Patients With Moderate-to-Severe Pruritus
Status: Enrolling, Phase II
Updated: 12/31/1969
Cara Therapeutics Study Site
mi
from
Plano, TX
Click here to add this to my saved trials
Rheumatology Clinical Trial
Improving Rehabilitation Outcomes After Total Hip Arthroplasty
Status: Enrolling
Updated: 12/31/1969
Rocky Mountain Regional VA Medical Center, Aurora, CO
mi
from
Aurora, CO
Click here to add this to my saved trials
Alopecia Areata Clinical Trial
A Study of Baricitinib (LY3009104) in Participants With Severe or Very Severe Alopecia Areata
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Skin Care Physicians of Georgia
mi
from
Macon, GA
Click here to add this to my saved trials
Alopecia Areata Clinical Trial
A Study of Baricitinib (LY3009104) in Participants With Severe or Very Severe Alopecia Areata
Status: Enrolling, Phase II, III
Updated: 12/31/1969
University of Utah MidValley Dematology
mi
from
Murray, UT
Click here to add this to my saved trials
Alopecia Areata Clinical Trial
A Study of Baricitinib (LY3009104) in Participants With Severe or Very Severe Alopecia Areata
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Stanford Health Care
mi
from
Redwood City, CA
Click here to add this to my saved trials
Alopecia Areata Clinical Trial
A Study of Baricitinib (LY3009104) in Participants With Severe or Very Severe Alopecia Areata
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Stephen L Miller, MD, PA
mi
from
San Antonio, TX
Click here to add this to my saved trials
AL Amyloidosis Clinical Trial
Ixazomib Maintenance Study in Patients With AL Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Memorial Sloan Kettering Westchester
mi
from
Harrison, NY
Click here to add this to my saved trials
Heart Failure With Preserved Ejection Fraction Clinical Trial
Dapagliflozin Evaluation to Improve the LIVEs of Patients With PReserved Ejection Fraction Heart Failure.
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Ames, IA
Click here to add this to my saved trials
Heart Failure With Preserved Ejection Fraction Clinical Trial
Dapagliflozin Evaluation to Improve the LIVEs of Patients With PReserved Ejection Fraction Heart Failure.
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Charlotte, NC
Click here to add this to my saved trials
Heart Failure With Preserved Ejection Fraction Clinical Trial
Dapagliflozin Evaluation to Improve the LIVEs of Patients With PReserved Ejection Fraction Heart Failure.
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Columbus, OH
Click here to add this to my saved trials
Heart Failure With Preserved Ejection Fraction Clinical Trial
Dapagliflozin Evaluation to Improve the LIVEs of Patients With PReserved Ejection Fraction Heart Failure.
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Falls Church, VA
Click here to add this to my saved trials
Heart Failure With Preserved Ejection Fraction Clinical Trial
Dapagliflozin Evaluation to Improve the LIVEs of Patients With PReserved Ejection Fraction Heart Failure.
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Heart Failure With Preserved Ejection Fraction Clinical Trial
Dapagliflozin Evaluation to Improve the LIVEs of Patients With PReserved Ejection Fraction Heart Failure.
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Heart Failure With Preserved Ejection Fraction Clinical Trial
Dapagliflozin Evaluation to Improve the LIVEs of Patients With PReserved Ejection Fraction Heart Failure.
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Madison, WI
Click here to add this to my saved trials
Heart Failure With Preserved Ejection Fraction Clinical Trial
Dapagliflozin Evaluation to Improve the LIVEs of Patients With PReserved Ejection Fraction Heart Failure.
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Mobile, AL
Click here to add this to my saved trials
Heart Failure With Preserved Ejection Fraction Clinical Trial
Dapagliflozin Evaluation to Improve the LIVEs of Patients With PReserved Ejection Fraction Heart Failure.
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Naples, FL
Click here to add this to my saved trials
Heart Failure With Preserved Ejection Fraction Clinical Trial
Dapagliflozin Evaluation to Improve the LIVEs of Patients With PReserved Ejection Fraction Heart Failure.
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Saint Augustine, FL
Click here to add this to my saved trials
Heart Failure With Preserved Ejection Fraction Clinical Trial
Dapagliflozin Evaluation to Improve the LIVEs of Patients With PReserved Ejection Fraction Heart Failure.
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
Heart Failure With Preserved Ejection Fraction Clinical Trial
Dapagliflozin Evaluation to Improve the LIVEs of Patients With PReserved Ejection Fraction Heart Failure.
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Tullahoma, TN
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Zinc Supplement Before or With Food in Generally Healthy Men
Status: Enrolling
Updated: 12/31/1969
UCSF Benioff Children's Hospital Oakland Research Institute
mi
from
Oakland, CA
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
The CARILLON Trial - Assessment of the Carillon® Mitral Contour System® in Treating Functional Mitral Regurgitation Associated With Heart Failure
Status: Enrolling
Updated: 12/31/1969
Henrico Doctor's Hospital
mi
from
Henrico, VA
Click here to add this to my saved trials
Psoriatic Arthritis Clinical Trial
Clinical Impact of Acthar in the Psoriatic Arthritis Patient (CLIPS)
Status: Enrolling, Phase IV
Updated: 12/31/1969
IRIS Research and Development
mi
from
Plantation, FL
Click here to add this to my saved trials
Renal Cell Carcinoma Clinical Trial
A Study of Pazopanib With or Without Abexinostat in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma (RENAVIV)
Status: Enrolling, Phase III
Updated: 12/31/1969
Medical Oncology Associates PS (dba Summit Cancer Centers)
mi
from
Spokane, WA
Click here to add this to my saved trials
Neurology Clinical Trial
EMG Training for Altering Activation Patterns After Stroke
Status: Enrolling
Updated: 12/31/1969
Shirley Ryan AbilityLab
mi
from
Chicago, IL
Click here to add this to my saved trials
Hematology Clinical Trial
ATHN 7: Hemophilia Natural History Study
Status: Enrolling, Phase
Updated: 12/31/1969
Michigan State University Center for Bleeding and Clotting Disorders
mi
from
East Lansing, MI
Click here to add this to my saved trials
Hematology Clinical Trial
ATHN 7: Hemophilia Natural History Study
Status: Enrolling, Phase
Updated: 12/31/1969
Kansas City Regional Hemophilia Center
mi
from
Kansas City, KS
Click here to add this to my saved trials
Hematology Clinical Trial
ATHN 7: Hemophilia Natural History Study
Status: Enrolling, Phase
Updated: 12/31/1969
Arizona Hemophilia and Thrombosis Center at Phoenix Children's Hospital
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Hematology Clinical Trial
ATHN 7: Hemophilia Natural History Study
Status: Enrolling, Phase
Updated: 12/31/1969
Washington Center for Bleeding Disorders Bloodworks Northwest d/b/a Puget Sound Blood Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Breast Cancer Clinical Trial
DS-8201a Versus T-DM1 for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive, Unresectable and/or Metastatic Breast Cancer Previously Treated With Trastuzumab and Taxane [DESTINY-Breast03]
Status: Enrolling, Phase III
Updated: 12/31/1969
The Sarah Cannon Research Institute
mi
from
Chattanooga, TN
Click here to add this to my saved trials
Birth Asphyxia With Neurologic Involvement Clinical Trial
Umbilical Cord Milking in Non-Vigorous Infants - NIRS Sub-study (MINVI_NIRS)
Status: Enrolling
Updated: 12/31/1969
Governors of University of Alberta
mi
from
Edmonton,
Click here to add this to my saved trials
Diabetic Macular Edema Clinical Trial
A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema (YOSEMITE)
Status: Enrolling, Phase III
Updated: 12/31/1969
Western Carolina Retinal Associate PA
mi
from
Asheville, NC
Click here to add this to my saved trials
Diabetic Macular Edema Clinical Trial
A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema (YOSEMITE)
Status: Enrolling, Phase III
Updated: 12/31/1969
Emerson Clinical Research Institute
mi
from
Falls Church, VA
Click here to add this to my saved trials
Diabetic Macular Edema Clinical Trial
A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema (YOSEMITE)
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Utah; Division of Gastroenterology/Hepatology
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Diabetic Macular Edema Clinical Trial
A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema (YOSEMITE)
Status: Enrolling, Phase III
Updated: 12/31/1969
W Coast Retina Med Group Inc
mi
from
San Francisco, CA
Click here to add this to my saved trials
Diabetic Macular Edema Clinical Trial
A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema
Status: Enrolling, Phase III
Updated: 12/31/1969
Northwestern Medical Group/Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
Diabetic Macular Edema Clinical Trial
A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema
Status: Enrolling, Phase III
Updated: 12/31/1969
Cleveland Clinic Foundation; Cole Eye Institute
mi
from
Cleveland, OH
Click here to add this to my saved trials
Diabetic Macular Edema Clinical Trial
A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema
Status: Enrolling, Phase III
Updated: 12/31/1969
Retina Associates of St. Louis
mi
from
Florissant, MO
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Establishing Muscle Impedance Parameters With Electrical Impedance Myography
Status: Enrolling
Updated: 12/31/1969
Yale Physicians Building
mi
from
New Haven, CT
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Anchorage Associates in Radiation Medicine
mi
from
Anchorage, AK
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Northwell Health Imbert Cancer Center
mi
from
Bay Shore, NY
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Siteman Cancer Center at West County Hospital
mi
from
Creve Coeur, MO
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Great Lakes Cancer Management Specialists-Doctors Park
mi
from
East China Township, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Sanford South University Medical Center
mi
from
Fargo, ND
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Sanford Broadway Medical Center
mi
from
Fargo, ND
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
UPMC Pinnacle Cancer Center/Community Osteopathic Campus
mi
from
Harrisburg, PA
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
PeaceHealth Saint John Medical Center
mi
from
Longview, WA
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Saint Mary's Oncology/Hematology Associates of Marlette
mi
from
Marlette, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Sovah Health Martinsville
mi
from
Martinsville, VA
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Saint Alphonsus Medical Center-Nampa
mi
from
Nampa, ID
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Bon Secours DePaul Medical Center
mi
from
Norfolk, VA
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Mercy Health Perrysburg Cancer Center
mi
from
Perrysburg, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
WellSpan Health-York Hospital
mi
from
York, PA
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Huron Gastroenterology PC
mi
from
Ypsilanti, MI
Click here to add this to my saved trials
Heart Failure Clinical Trial
Personalized CRT - MPP Post Approval Study
Status: Enrolling, Phase
Updated: 12/31/1969
UZ Leuven - Campus Gasthuisberg
mi
from
Leuven,
Click here to add this to my saved trials
Heart Failure Clinical Trial
Personalized CRT - MPP Post Approval Study
Status: Enrolling, Phase
Updated: 12/31/1969
Kootenai Heart Clinics Northwest
mi
from
Spokane, WA
Click here to add this to my saved trials
Refractory Major Depressive Disorder Clinical Trial
A Long Term Study of ALKS 5461 in the Treatment of Refractory Major Depressive Disorder (MDD)
Status: Enrolling, Phase III
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Pikesville, MD
Click here to add this to my saved trials
Solid Tumors Clinical Trial
Dose Escalation of RMC-4630 Monotherapy in Relapsed/Refractory Solid Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
Honor Health Research Institute
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Peripheral Arterial Disease Clinical Trial
Evaluation of the FreedomFlow™ Orbital Atherectomy System to Treat Peripheral Artery Disease
Status: Enrolling
Updated: 12/31/1969
Eastlake Cardiovascular, PC
mi
from
Saint Clair Shores, MI
Click here to add this to my saved trials
Paroxysmal Supraventricular Tachycardia Clinical Trial
Safety Study of Intranasal Etripamil for the Termination of Spontaneous Episodes of PSVT. NODE-302
Status: Enrolling, Phase III
Updated: 12/31/1969
The Presbyterian Hospital DBA Novant Health Heart and Vascular Institute
mi
from
Charlotte, NC
Click here to add this to my saved trials
Paroxysmal Supraventricular Tachycardia Clinical Trial
Safety Study of Intranasal Etripamil for the Termination of Spontaneous Episodes of PSVT. NODE-302
Status: Enrolling, Phase III
Updated: 12/31/1969
Hatton Institute for Research & Education, Trihealth, Inc. - cardiology
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Paroxysmal Supraventricular Tachycardia Clinical Trial
Safety Study of Intranasal Etripamil for the Termination of Spontaneous Episodes of PSVT. NODE-302
Status: Enrolling, Phase III
Updated: 12/31/1969
Sima Research Clinic
mi
from
Miami, FL
Click here to add this to my saved trials
Paroxysmal Supraventricular Tachycardia Clinical Trial
Safety Study of Intranasal Etripamil for the Termination of Spontaneous Episodes of PSVT. NODE-302
Status: Enrolling, Phase III
Updated: 12/31/1969
Manshadi Heart Institute Inc
mi
from
Stockton, CA
Click here to add this to my saved trials
Uremic Pruritus Clinical Trial
CR845-CLIN3103: A Global Study to Evaluate the Safety and Efficacy of CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus
Status: Enrolling, Phase III
Updated: 12/31/1969
Cara Therapeutics Study Site
mi
from
Orlando, FL
Click here to add this to my saved trials
Uremic Pruritus Clinical Trial
CR845-CLIN3103: A Global Study to Evaluate the Safety and Efficacy of CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus
Status: Enrolling, Phase III
Updated: 12/31/1969
Cara Therapeutics Study Site
mi
from
Saint George, UT
Click here to add this to my saved trials
Recurrent Vulvovaginal Candidiasis Clinical Trial
A Study of Oral VT-1161 for the Treatment of Patients With Recurrent Vaginal Candidiasis (Yeast Infection)
Status: Enrolling, Phase III
Updated: 12/31/1969
Lawrence Ob-Gyn Assoc., PC
mi
from
Lawrenceville, NJ
Click here to add this to my saved trials
Cannabis Use Disorder Clinical Trial
Lorcaserin for Cannabis Use Disorder
Status: Enrolling, Phase
Updated: 12/31/1969
Columbia Substance Treatment and Research Service
mi
from
New York, NY
Click here to add this to my saved trials
Endocrinology, Pharmacology / Toxicology, Other Clinical Trial
BPX-501 T Cells Infused Post Stem Cell Transplant in Pediatrics With Non-Malignant Disorders Ineligible for BPU004 Study
Status: Enrolling, Phase
Updated: 12/31/1969
Stanford University; Division of Pediatric Stem Cell Transplant & Regenerative Medicine
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Cutaneous Lupus Clinical Trial
Study of the Efficacy of 532nm Laser and 1064 nm Laser in the Treatment of Cutaneous Lupus Erythematous Versus Topical Corticosteroids Alone
Status: Enrolling
Updated: 12/31/1969
UCF Health Lake Nona Office
mi
from
Orlando, FL
Click here to add this to my saved trials
Glaucoma Clinical Trial
Investigation of the Glaukos® Trabecular Micro-Bypass System, Model iS3, in Subjects With Refractory Glaucoma
Status: Enrolling
Updated: 12/31/1969
Glaucoma Associates of TX
mi
from
Dallas, TX
Click here to add this to my saved trials
Oncology, Psychiatry / Psychology Clinical Trial
The Promoting Resilience in Stress Management (PRISM) Intervention: a Multi-site Randomized Controlled Trial for Adolescents and Young Adults Receiving Hematopoietic Cell Transplantation
Status: Enrolling, Phase III
Updated: 12/31/1969
Seattle Children's Hospital Cancer and Blood Disorders Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Pediatric Abusive Head Trauma Clinical Trial
The CDR Implementation Trial
Status: Enrolling
Updated: 12/31/1969
Childrens Hospital of Richmond at Virginia Commonwealth University
mi
from
Richmond, VA
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
IHA Hematology Oncology Consultants-Brighton
mi
from
Brighton, MI
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Saint Alphonsus Cancer Care Center-Caldwell
mi
from
Caldwell, ID
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Hematology Oncology Consultants-Clarkston
mi
from
Clarkston, MI
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Great Lakes Cancer Management Specialists-Macomb Medical Campus
mi
from
Macomb, MI
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Michigan Breast Specialists-Macomb Township
mi
from
Macomb, MI
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Fairview Maple Grove Medical Center
mi
from
Maple Grove, MN
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Kaiser Permanente Washington
mi
from
Seattle, WA
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
PeaceHealth United General Medical Center
mi
from
Sedro-Woolley, WA
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Southwest Illinois Health Services LLP
mi
from
Swansea, IL
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Saint Joseph Health System-Tawas City
mi
from
Tawas City, MI
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Advanced Breast Care Center PLLC
mi
from
Warren, MI
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Michigan Breast Specialists-Warren
mi
from
Warren, MI
Click here to add this to my saved trials
Chronic Obstructive Pulmonary Disease (COPD) Clinical Trial
The CAPTURE Study: Validating a Unique COPD Case Finding Tool in Primary Care (Aim 2)
Status: Enrolling, Phase
Updated: 12/31/1969
High Plains Research Network
mi
from
Aurora, CO
Click here to add this to my saved trials
Suicide Clinical Trial
Group ("Project Life Force") vs. Individual Suicide Safety Planning RCT
Status: Enrolling
Updated: 12/31/1969
Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Single and Multiple Ascending Doses of MEDI6570 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling, Phase I
Updated: 12/31/1969
Clinical Research Facility
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Study to Evaluate Long-Term Safety of ASN002 in Subjects With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase II
Updated: 12/31/1969
Institute of Skin Advancement Medical, Surgical, Costmetic & Laser Dermatology
mi
from
Calgary,
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Study to Evaluate Long-Term Safety of ASN002 in Subjects With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase II
Updated: 12/31/1969
DermDox Centers for Dermatology
mi
from
Hazleton, PA
Click here to add this to my saved trials